Literature DB >> 32745647

Bicoronal Incision and Frontal-Basal Approach for Removal of Sinonasal Fibrous Dysplasia Complicated by Orbital Subperiosteal Abscess.

Chih-Yu Hu1, Chieh-Tsai Wu2, Chien-Cheng Chen3, Chia-Hsiang Fu4.   

Abstract

BACKGROUND: Fibrous dysplasia (FD) is a benign, slowly progressive disease resulting from the replacement of normal bone by fibro-osseous tissue. The incidence of craniofacial involvement of FD is as high as 23%. Sinonasal involvement of FD may lead to obstruction of the natural sinus ostium, resulting in acute sinusitis. We present a rare case of sinonasal FD complicated by subperiosteal abscess that was removed by bicoronal incision and frontal-basal approach in the second surgery. CASE DESCRIPTION: A 16-year-old male patient presented with painful swelling on his left eye that had persisted for 2 days. Transnasal endoscopic drainage of the left orbital subperiosteal abscess was performed and progressive improvement of the swelling of the left eye was noted. After the acute phase, transcranial removal of the sinonasal bony lesion and mesh reconstruction of the left orbital wall were performed. There has been no progression of FD to date, with 24 months of follow-up.
CONCLUSIONS: After the acute phase, radical excision with reconstruction or debulking surgery after skeletal maturation may prevent recurrence. Although malignant transformation is rare, long-term follow-up is necessary for FD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abscess; Bicoronal incision; Fibrous dysplasia; Sinusitis

Year:  2020        PMID: 32745647     DOI: 10.1016/j.wneu.2020.07.167

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Orbital Abscess Developed Apart From Paranasal Sinusitis and Dacryocystitis in Fibrous Dysplasia.

Authors:  Yasuhiro Takahashi; Shinjiro Kono; Tatsuro Yokoyama; Tessei Kuruma; Aric Vaidya; Hirohiko Kakizaki
Journal:  Cureus       Date:  2022-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.